Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907.

Kornblith AB, Lan L, Archer L, Partridge A, Kimmick G, Hudis C, Winer E, Casey R, Bennett S, Cohen HJ, Muss HB.

J Clin Oncol. 2011 Mar 10;29(8):1022-8. doi: 10.1200/JCO.2010.29.9859. Epub 2011 Feb 7.

2.

Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group.

Martin M, Villar A, Sole-Calvo A, Gonzalez R, Massuti B, Lizon J, Camps C, Carrato A, Casado A, Candel MT, Albanell J, Aranda J, Munarriz B, Campbell J, Diaz-Rubio E; GEICAM Group (Spanish Breast Cancer Research Group), Spain.

Ann Oncol. 2003 Jun;14(6):833-42. Review.

3.
4.

Adjuvant chemotherapy for older adults with breast cancer: making the standard a standard.

Pal SK, Mortimer J.

Womens Health (Lond). 2009 Sep;5(5):481-4. doi: 10.2217/whe.09.43. Review.

PMID:
19702447
5.

Efficacy and toxicity of capecitabine-based chemotherapy in patients with metastatic or advanced breast cancer: results from ten randomized trials.

Wang Y, Yang H, Wei JF, Meng L.

Curr Med Res Opin. 2012 Dec;28(12):1911-9. doi: 10.1185/03007995.2012.748655. Epub 2012 Nov 27. Review.

PMID:
23145857
6.

Quality-of-life considerations in the treatment of early-stage breast cancer in the elderly.

Reimer T, Gerber B.

Drugs Aging. 2010 Oct 1;27(10):791-800. doi: 10.2165/11584700-000000000-00000. Review.

PMID:
20883059
7.

Breast cancer, DPYD mutations and capecitabine-related ileitis: description of two cases and a review of the literature.

Mokrim M, Aftimos PG, Errihani H, Piccart-Gebhart M.

BMJ Case Rep. 2014 Apr 19;2014. pii: bcr2014203647. doi: 10.1136/bcr-2014-203647. Review.

8.

Single-agent vs combination therapy in advanced breast cancer: potential roles of capecitabine.

Hudis CA.

Oncology (Williston Park). 2002 Oct;16(10 Suppl 12):13-6. Review.

9.

Current and planned trials with capecitabine in adjuvant/neoadjuvant therapy of breast cancer.

Livingston R.

Oncology (Williston Park). 2002 Oct;16(10 Suppl 12):29-32. Review.

10.

Effectiveness of psychoeducational support on quality of life in early-stage breast cancer patients: a systematic review and meta-analysis of randomized controlled trials.

Matsuda A, Yamaoka K, Tango T, Matsuda T, Nishimoto H.

Qual Life Res. 2014 Feb;23(1):21-30. doi: 10.1007/s11136-013-0460-3. Epub 2013 Jul 24. Review.

11.
12.

Antineoplastic agent-associated serpentine supravenous hyperpigmentation: superficial venous system hyperpigmentation following intravenous chemotherapy.

Geddes ER, Cohen PR.

South Med J. 2010 Mar;103(3):231-5. doi: 10.1097/SMJ.0b013e3181ce0f5e. Review.

PMID:
20134385
13.

Adjuvant chemotherapy of breast cancer in the older patient.

Taylor WC, Muss HB.

Oncology (Williston Park). 2010 Jun;24(7):608-13. Review.

14.

Metallic taste in cancer patients treated with chemotherapy.

IJpma I, Renken RJ, Ter Horst GJ, Reyners AK.

Cancer Treat Rev. 2015 Feb;41(2):179-86. doi: 10.1016/j.ctrv.2014.11.006. Epub 2014 Dec 5. Review.

PMID:
25499998
15.

Optimizing treatment benefit in older breast cancer patients.

Lichtman SM.

Oncology (Williston Park). 2010 Jun;24(7):624-5. Review. No abstract available.

16.

Quality of life of patients with lung cancer.

Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A.

Onco Targets Ther. 2016 Feb 29;9:1023-8. doi: 10.2147/OTT.S100685. eCollection 2016. Review.

17.

Quality of life outcomes in patients with breast cancer.

Paraskevi T.

Oncol Rev. 2012 Jan 30;6(1):e2. doi: 10.4081/oncol.2012.e2. eCollection 2012 Mar 5. Review.

18.

[Acute coronary syndrome after chemotherapy].

Vastbinder MB, Drost H, Muller EW.

Ned Tijdschr Geneeskd. 2014;158:A6940. Review. Dutch.

PMID:
24800798
19.

How to compare quality of life of breast cancer patients in clinical trials. International Breast Cancer Study Group.

Gelber RD, Cole BF, Goldhirsch A.

Recent Results Cancer Res. 1993;127:221-33. Review. No abstract available.

PMID:
8502819
Items per page

Supplemental Content

Write to the Help Desk